Syncona Limited is a fund specializes in investments in hedge, equity and long-term alternative investment funds across multiple asset classes. It manages private equity, debt, fixed income and alternative investments. The fund prefers to invest in healthcare and life sciences sector with focus on Cell therapy, gene therapy, biologics and small molecules. The fund invests in the public equity and fixed income markets across the globe. It targets attractive medium to long term returns by investing in leading long-only and alternative investment funds with proven managers and across multiple asset classes. The firm invests in separately managed account portfolios.

Currency in GBP	2026
Eps	-0.01
Epsdiluted	-0.01
Weighted Average Shs Out	608.37 Million
Weighted Average Shs Out Dil	608.81 Million
Period	FY
Ebitda	N/A
Net Cash Provided By Operating Activities	N/A

Syncona Limited Annual Reports (10-K)